ADMA vs VICI · P/E 22, rev $426.5M vs P/E 9.3, rev $3.85B
ADMA Biologics Inc (ADMA) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported ADMA revenue for 2024-12-31 was $426.5M. Net income was $197.7M. Revenue was up 65.2% from 2023-12-31 to 2024-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the ADMA and VICI stock pages for the full models.
Not investment advice.